Obesity

Wegovy
Health Tech

Hims & Hers stock drops 30% after Novo Nordisk terminates deal

Hims & Hers stock plunged 30% on Monday after Novo Nordisk abruptly ended a collaboration to offer direct access to its weight loss drug Wegovy.
Heather Landi Jun 23, 2025 12:00pm
Anti-obesity medication in a tiny shopping cart

How much GLP-1 prescriptions for weight management have grown

May 28, 2025 1:03pm
Two dosing pens of semaglutide

CMS excludes anti-obesity drug coverage under Medicare, Medicaid

Apr 4, 2025 4:28pm
Two injectable medications with a tape measure wrapped around them

Omada partners with CVS Caremark on weight management program

Mar 28, 2025 4:45pm
Two injectable medications with a tape measure wrapped around them

Industry Voices—The GLP-1 status quo is no longer acceptable

Mar 7, 2025 8:47am
finance numbers tape money

68 healthcare orgs sign letter pushing for obesity care coverage

Mar 6, 2025 4:40pm